Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
6728Tv2ZjARrKGY6